Anti-viral consortium gets $2M funding

Peterborough, ON – The International Consortium on Anti-Virals, a Canadian consortium headquartered at Trent University with a worldwide research network of 200 scientists and private sector partners from 21 countries, is receiving $2 million in funding from the Ontario government.

The funding will support the consortium’s efforts in discovering and commercializing new anti-virals that will treat infectious viral diseases and help to develop new drugs that target viral diseases faster and more affordably by strengthening information sharing among the consortium’s industry partners.